Biological Drug Products: Development and Strategies

his book overviews the fundamental aspects, challenges, and development strategies for biological drug entities. It is divided into 5 parts, covering general aspects in the development of biologics (Part 1) and challenges and strategies in the development of specific types of biologics (Parts 2-5)....

全面介紹

Saved in:
書目詳細資料
主要作者: Wang,Wei
其他作者: Manmohan singh
格式: 圖書
語言:英语
出版: Newdelhi Wiley 2018
主題:
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

MARC

LEADER 00000nam a22000007a 4500
008 251103b |||||||| |||| 00| 0 eng d
020 |a 9788126577606 
082 |a 615.19  |b WAN 
100 |a  Wang,Wei  |9 11820 
245 |a Biological Drug Products: Development and Strategies  
260 |a Newdelhi  |b Wiley  |c 2018 
300 |a xv,728p 
520 |a his book overviews the fundamental aspects, challenges, and development strategies for biological drug entities. It is divided into 5 parts, covering general aspects in the development of biologics (Part 1) and challenges and strategies in the development of specific types of biologics (Parts 2-5). In the overview section, contributing authors discuss the development process, safety and clinical assessments, manufacturing, and regulatory and intellectual property issues. Following this opening, the major classes of biologics are proteins and peptides, vaccines, oligonucleotides, and gene and regenerative medicines. A concluding section details administration and delivery routes and systems. The book incorporates both lessons learned and future directions to make for a valuable resource and reference for pharmaceutical scientists involved in the dynamic field of biologics. 
650 |a biological drug entities  |9 11821 
700 |a Manmohan singh  |9 11822 
952 |0 0  |1 0  |2 ddc  |4 0  |6 615_190000000000000_WAN  |7 0  |9 20094  |a 50008178  |b 50008178  |d 2025-11-03  |e Mehul Traders  |g 4546.50  |l 0  |o 615.19 WAN  |p JP002276  |r 2025-11-03 16:04:57  |v 6495.00  |w 2025-11-03  |y RB 
999 |c 9868  |d 9868